- Home
- STAA
as of 01-16-2026 3:40pm EST
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | MONROVIA |
| Market Cap: | 1.2B | IPO Year: | N/A |
| Target Price: | $24.56 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.50 - $30.81 | Next Earning Date: | 02-10-2026 |
| Revenue: | $230,591,000 | Revenue Growth: | -32.42% |
| Revenue Growth (this year): | -16.35% | Revenue Growth (next year): | 21.97% |
AI-Powered STAA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of STAAR Surgical Company (STAA)
10% Owner
Avg Cost/Share
$11.03
Shares
27,485
Total Value
$606,137.70
Owned After
15,453,629
10% Owner
Avg Cost/Share
$10.97
Shares
3,240
Total Value
$71,082.04
Owned After
15,453,629
10% Owner
Avg Cost/Share
$11.00
Shares
66,467
Total Value
$1,462,300.59
Owned After
15,453,629
10% Owner
Avg Cost/Share
$10.85
Shares
336,946
Total Value
$7,284,281.10
Owned After
15,453,629
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Jan 9, 2026 | Buy | $11.03 | 27,485 | $606,137.70 | 15,453,629 | |
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Jan 8, 2026 | Buy | $10.97 | 3,240 | $71,082.04 | 15,453,629 | |
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Jan 7, 2026 | Buy | $11.00 | 66,467 | $1,462,300.59 | 15,453,629 | |
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Jan 6, 2026 | Buy | $10.85 | 336,946 | $7,284,281.10 | 15,453,629 |
Compare STAA vs Leading Stocks
See how STAA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "STAA STAAR Surgical Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.